Illumisoft Plans CHAIR-Led Hospital Studies, Gains DTC Eligibility
Illumisoft outlined plans for hospital research on SaniLume with CHAIR, including installations in MB and BC and 13 linked studies targeted to start in Nov. 2026, subject to funding and agreements. The company also gained DTC eligibility for its shares in the U.S.